Methods In this retrospective analysis of GLP-1RAs prescribed to patients with IBS at our institution from 2013-2023, we assessed the association of IBS subtype- and patient-related (age, race, body mass index, insurance, diabetes, gastroesophageal reflux disease) factors on the number and reasons for agent switches throughout the treatment course
Sustainable behavioural change The medication helps patients reset their relationship with food, but long-term success depends on gradual habit building
The most common type used in UK pharmacies is hydroxocobalamin , which is the version recommended by the NHS for treating B12 deficiency
Nitric oxide system research, including L-NAME blockade and L-arginine rescue paradigms that sit at the centre of the proposed BPC-157 mechanism
Not Intended To Diagnose Treat Cure Or Prevent Any Disease